- Home
- LVWR vs TSHA Comparison
LVWR vs TSHA Comparison
Compare LVWR & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVWR
- TSHA
- Stock Information
- Founded
- LVWR 2022
- TSHA 2019
- Country
- LVWR United States
- TSHA United States
- Employees
- LVWR N/A
- TSHA N/A
- Industry
- LVWR
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- LVWR
- TSHA Health Care
- Exchange
- LVWR Nasdaq
- TSHA Nasdaq
- Market Cap
- LVWR N/A
- TSHA 356.7M
- IPO Year
- LVWR N/A
- TSHA 2020
- Fundamental
- Price
- LVWR $2.13
- TSHA $1.93
- Analyst Decision
- LVWR Hold
- TSHA Strong Buy
- Analyst Count
- LVWR 1
- TSHA 8
- Target Price
- LVWR $7.25
- TSHA $6.63
- AVG Volume (30 Days)
- LVWR 28.3K
- TSHA 1.7M
- Earning Date
- LVWR 04-24-2025
- TSHA 05-13-2025
- Dividend Yield
- LVWR N/A
- TSHA N/A
- EPS Growth
- LVWR N/A
- TSHA N/A
- EPS
- LVWR N/A
- TSHA N/A
- Revenue
- LVWR $26,633,000.00
- TSHA $8,333,000.00
- Revenue This Year
- LVWR $249.13
- TSHA N/A
- Revenue Next Year
- LVWR $98.53
- TSHA N/A
- P/E Ratio
- LVWR N/A
- TSHA N/A
- Revenue Growth
- LVWR N/A
- TSHA N/A
- 52 Week Low
- LVWR $1.90
- TSHA $1.19
- 52 Week High
- LVWR $9.00
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- LVWR 44.11
- TSHA 64.48
- Support Level
- LVWR $1.95
- TSHA $1.59
- Resistance Level
- LVWR $2.11
- TSHA $1.87
- Average True Range (ATR)
- LVWR 0.15
- TSHA 0.12
- MACD
- LVWR 0.05
- TSHA 0.02
- Stochastic Oscillator
- LVWR 45.45
- TSHA 94.44
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.